Cases & Deals

  • Home
  • Practices
  • MindRank develops global patent portfolio related to clinical-stage small molecule therapeutics for treatment of metabolic disorders

Share

MindRank develops global patent portfolio related to clinical-stage small molecule therapeutics for treatment of metabolic disorders

October 2025

Client(s) MindRank AI Ltd.

Jones Day is representing MindRank AI Ltd., an artificial intelligence (AI)-powered drug discovery company, in the development of global patent portfolios related to clinical-stage small molecule therapeutics and methods for the treatment of various metabolic disorders.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.